查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978302

全球可生物分解支架市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Biodegradable Stents Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，可生物分解支架市場規模將從 2025 年的 4.367 億美元成長至 8.9577 億美元，2026 年至 2034 年的複合年成長率為 8.31%。

隨著心血管治療醫療技術的進步，全球可分解支架市場正迅速成長。可分解支架旨在暫時支撐阻塞的動脈，並在動脈癒合後逐漸被人體吸收。這減少了與傳統金屬支架相關的長期併發症，並改善了患者的復原效果。

心血管疾病發生率的上升是市場成長的主要驅動力。生活方式的改變、人口老化以及冠狀動脈疾病病例的增加，都導致心臟介入治療的需求增加。醫療機構正在採用可生物分解支架，因為它們可以提高安全性，並使部分患者無需植入永久性植入。

展望未來，隨著生物材料和醫療設備技術研究的不斷深入，市場預計將持續擴張。製造商正在研發具有卓越強度和可控分解特性的先進生物分解材料。隨著微創心血管治療的日益普及，生物分解支架將在現代心臟病治療中發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球可生物分解支架市場：依支架類型分類

  • 市場分析、洞察與預測
  • 冠狀動脈支架
  • 周邊動脈支架

第5章 全球可生物分解支架市場：依材料類型分類

  • 市場分析、洞察與預測
  • 聚合物基
  • 金屬底座

第6章 全球可生物分解支架市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 心臟導管檢查室
  • 門診手術中心

第7章 全球可生物分解支架市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Boston Scientific
    • Abbott
    • Elixir Medical Corporation
    • Kyoto Medical Planning Co. Ltd
    • Biotronik
    • Terumo Corporation
    • Medtronic Plc
    • B. Braun Melsungen AG
    • Arterial Remodeling Technologies SA
    • Amaranth Medical Inc
簡介目錄
Product Code: VMR112114534

The Biodegradable Stents Market size is expected to reach USD 895.77 Million in 2034 from USD 436.70 Million (2025) growing at a CAGR of 8.31% during 2026-2034.

The global biodegradable stents market is growing rapidly as medical technology advances in cardiovascular treatments. Biodegradable stents are designed to temporarily support blocked arteries and gradually dissolve in the body after the artery heals. This reduces the long-term complications associated with traditional metal stents and improves patient recovery outcomes.

The increasing prevalence of cardiovascular diseases is a major driver of market growth. Lifestyle changes, aging populations, and rising cases of coronary artery disease are leading to more interventional cardiology procedures. Healthcare providers are adopting biodegradable stents as they offer improved safety and eliminate the need for permanent implants in some patients.

Looking ahead, the market is expected to expand as research in biomaterials and medical device technology continues to progress. Manufacturers are developing advanced biodegradable materials that provide better strength and controlled degradation. As minimally invasive cardiovascular procedures become more common, biodegradable stents will play a key role in modern heart disease treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Stent Type

  • Coronary Artery Stents
  • Peripheral Artery Stents

By Material Type

  • Polymer-based
  • Metal-based

By End-user

  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgery Centers

COMPANIES PROFILED

  • Boston Scientific, Abbott, Elixir Medical Corporation, Kyoto Medical Planning Co Ltd, Biotronik, Terumo Corporation, Medtronic Plc, B Braun Melsungen AG, Arterial Remodeling Technologies SA, Amaranth Medical Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIODEGRADABLE STENTS MARKET: BY STENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Stent Type
  • 4.2. Coronary Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Peripheral Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIODEGRADABLE STENTS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material Type
  • 5.2. Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Metal-based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIODEGRADABLE STENTS MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cardiac Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIODEGRADABLE STENTS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Stent Type
    • 7.2.2 By Material Type
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Stent Type
    • 7.3.2 By Material Type
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Stent Type
    • 7.4.2 By Material Type
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Stent Type
    • 7.5.2 By Material Type
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Stent Type
    • 7.6.2 By Material Type
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIODEGRADABLE STENTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Boston Scientific
    • 9.2.2 Abbott
    • 9.2.3 Elixir Medical Corporation
    • 9.2.4 Kyoto Medical Planning Co. Ltd
    • 9.2.5 Biotronik
    • 9.2.6 Terumo Corporation
    • 9.2.7 Medtronic Plc
    • 9.2.8 B. Braun Melsungen AG
    • 9.2.9 Arterial Remodeling Technologies SA
    • 9.2.10 Amaranth Medical Inc